📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Infarct Size Following Treatment With Second- Versus Third-Generation P2Y12 Antagonists in Patients With Multivessel Coronary Disease at ST-Segment Elevation Myocardial Infarction in the CvLPRIT Study. (2016)

First Author: Khan JN

Attributed to: Complete Versus Lesion-only Primary PCI pilot -Cardiac MRI sub study (CVLPRI-t-CMR) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1161/jaha.116.003403

PubMed Identifier: 27247336

Publication URI: http://europepmc.org/abstract/MED/27247336

Type: Journal Article/Review

Volume: 5

Parent Publication: Journal of the American Heart Association

Issue: 6

ISSN: 2047-9980